Tax Risk Control Research Of ZY Company

In addition to legal sanctions,the outbreak of enterprise tax risks may damage the reputation and property of the enterprise,and even lead to the bankruptcy and bankruptcy of the enterprise.In recent years,with more and more cases of bankruptcy caused by potential or existing tax risks,enterprises pay more and more attention to the control of tax risks.As one of the effective means to manage tax risks,enterprises have paid more and more attention to the improvement of internal control construction of tax risks.The pharmaceutical manufacturing industry is related to national economy and people's livelihood,which is concerned by relevant government departments and the public.Therefore,its control and management of tax risks is particularly important.company is a medium-sized traditional Chinese medicine enterprise which focuses on pharmaceutical r&d,production and trade.First of all,based on the relevant theories of tax risk control,this paper analyzes the actual situation of ZY as a case.Then,by using analytic hierarchy process(AHP)asset management class,business class,and profitability ability index,short-term debt paying ability index data model is established to obtain data,and compare the index and industry index of ZY company,found that in recent years,although the ZY company's tax risk remained below the industry average,but the rising trend began in 2016,and in 2017,slightly more than industry average about tax risk,ZY company shall cause the necessary attention to this.Then,after further using the tax assessment indicators to conduct the ratio analysis of the financial data,it is found that the enterprise may have the problem of false increase cost and less revenue,which leads to the company's tax evasion and tax risks.Based on the qualitative analysis of tax risks,it is concluded that the company has revenue recognition,cost deduction,asset tax treatment,tax preferential policy implementation and tax risks involving invoices.Finally,based on the five major elements of internal control,based on the perspective of internal control,ZY company improves the tax risk management process and establishes a rational strategy for the internal control mechanism of tax risk.First,optimize the control of ZY company's tax risk environment.Through training the company's tax risk prevention and control consciousness,adding the company's tax risk control organization and strengthening the training and assessment of the professional ability of the fiscal and tax personnel;Second,the establishment of an effective tax risk assessment system,including the improvement of tax risk identification mechanisms,analysis mechanisms and coping mechanisms;Third,to strengthen tax risk control activities,through the optimization of tax workflow,the establishment of a tax risk early warning system,the establishment of a tax risk self-inspection system,the final regulatory effect;Fourth,strengthen the external and internal communication of tax risk;The fifth is to formulate tax risk supervision and feedback mechanism.lt is hoped that these countermeasures can help to improve the company's tax risk prevention and control system and give other pharmaceutical manufacturers some inspiration.